Compounds > tetradecanoylphorbol acetate
Page last updated: 2024-08-23

tetradecanoylphorbol acetate and ticlopidine

tetradecanoylphorbol acetate has been researched along with ticlopidine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chap, H; Defreyn, G; Delebassée, D; Douste-Blazy, L; Féliste, R; Maffrand, JP; Simon, MF; Vallée, E1
Cañizares, C; Herdoiza, M; Vivar, N1
Obata, Y; Oda, M; Yamamoto, N; Yokota, K1
Braun, M; Hermann, A; Rauch, BH; Schrör, K; Weber, AA1
Costello, C; Kim, J; Laurence, J; Mauro, M1

Other Studies

5 other study(ies) available for tetradecanoylphorbol acetate and ticlopidine

ArticleYear
Broad spectrum anti-platelet activity of ticlopidine and PCR 4099 involves the suppression of the effects of released ADP.
    Thrombosis research, 1987, Nov-15, Volume: 48, Issue:4

    Topics: Adenosine Diphosphate; Animals; Blood Platelets; Calcimycin; Clopidogrel; Diglycerides; Female; Platelet Aggregation Inhibitors; Rats; Serotonin; Tetradecanoylphorbol Acetate; Thrombin; Ticlopidine; Type C Phospholipases

1987
Role of the microtubular system in platelet aggregation.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 1994, Volume: 27, Issue:7

    Topics: Blood Platelets; Cimetidine; Colchicine; Concanavalin A; Cytochalasin B; Cytochalasin D; Humans; Microtubules; Platelet Aggregation; Tetradecanoylphorbol Acetate; Ticlopidine; Vinblastine

1994
Inhibitory effects of the new anti-platelet agent KBT-3022 and its metabolite on rabbit neutrophil function in vitro.
    Japanese journal of pharmacology, 1996, Volume: 70, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Binding Sites; Calcium; Cell Adhesion; Cilostazol; Complement C3-C5 Convertases; Complement C5a; Cyclooxygenase Inhibitors; Indomethacin; Leukotriene B4; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; Platelet Aggregation Inhibitors; Pyrroles; Rabbits; Structure-Activity Relationship; Superoxides; Tetradecanoylphorbol Acetate; Tetrazoles; Thiazoles; Ticlopidine

1996
Platelet CD40 ligand (CD40L)--subcellular localization, regulation of expression, and inhibition by clopidogrel.
    Platelets, 2001, Volume: 12, Issue:2

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Adult; Antigens, CD; Blood Platelets; Calcimycin; Calcium; CD40 Ligand; Cells, Cultured; Clopidogrel; Collagen; Cytoplasmic Granules; Cytoskeleton; Gene Expression Regulation; Humans; Ionophores; Male; P-Selectin; Peptide Fragments; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Subcellular Fractions; Tetradecanoylphorbol Acetate; Tetraspanin 30; Thrombin; Ticlopidine

2001
Role of transforming growth factor beta1 in microvascular endothelial cell apoptosis associated with thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome.
    American journal of hematology, 2001, Volume: 66, Issue:1

    Topics: Apoptosis; Cell Cycle; Cell Lineage; Cells, Cultured; Coronary Vessels; Culture Media, Serum-Free; Endothelium, Vascular; Extracellular Matrix Proteins; Fibronectins; Hemolytic-Uremic Syndrome; HIV Infections; Humans; Liver; Organ Specificity; Palatine Tonsil; Platelet Aggregation Inhibitors; Platelet Count; Purpura, Thrombotic Thrombocytopenic; RNA, Messenger; Skin; Tetradecanoylphorbol Acetate; Thrombospondins; Ticlopidine; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha

2001